B&G FOODS INC (BGS)

US05508R1068 - Common Stock

7.14  +0.04 (+0.56%)

After market: 7.14 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BGS. BGS was compared to 91 industry peers in the Food Products industry. There are concerns on the financial health of BGS while its profitability can be described as average. BGS is cheap, but on the other hand it scores bad on growth.



5

1. Profitability

1.1 Basic Checks

In the past year BGS was profitable.
In the past year BGS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BGS reported negative net income in multiple years.
In the past 5 years BGS always reported a positive cash flow from operatings.

1.2 Ratios

BGS's Return On Assets of -0.77% is on the low side compared to the rest of the industry. BGS is outperformed by 63.74% of its industry peers.
The Return On Equity of BGS (-3.48%) is worse than 63.74% of its industry peers.
The Return On Invested Capital of BGS (9.03%) is better than 81.32% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BGS is below the industry average of 8.80%.
The last Return On Invested Capital (9.03%) for BGS is above the 3 year average (5.03%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.77%
ROE -3.48%
ROIC 9.03%
ROA(3y)-0.15%
ROA(5y)1.08%
ROE(3y)-0.64%
ROE(5y)4.67%
ROIC(3y)5.03%
ROIC(5y)5.33%

1.3 Margins

Looking at the Operating Margin, with a value of 16.82%, BGS belongs to the top of the industry, outperforming 90.11% of the companies in the same industry.
BGS's Operating Margin has improved in the last couple of years.
BGS's Gross Margin of 21.87% is in line compared to the rest of the industry. BGS outperforms 51.65% of its industry peers.
In the last couple of years the Gross Margin of BGS has remained more or less at the same level.
Industry RankSector Rank
OM 16.82%
PM (TTM) N/A
GM 21.87%
OM growth 3Y-6.24%
OM growth 5Y3.76%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.37%
GM growth 5Y1.45%

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BGS is still creating some value.
Compared to 1 year ago, BGS has more shares outstanding
The number of shares outstanding for BGS has been increased compared to 5 years ago.
Compared to 1 year ago, BGS has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.45, we must say that BGS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.45, BGS is doing worse than 62.64% of the companies in the same industry.
BGS has a debt to FCF ratio of 18.12. This is a negative value and a sign of low solvency as BGS would need 18.12 years to pay back of all of its debts.
BGS's Debt to FCF ratio of 18.12 is in line compared to the rest of the industry. BGS outperforms 45.05% of its industry peers.
A Debt/Equity ratio of 2.40 is on the high side and indicates that BGS has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.40, BGS is doing worse than 87.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.4
Debt/FCF 18.12
Altman-Z 1.45
ROIC/WACC1.36
WACC6.62%

2.3 Liquidity

A Current Ratio of 1.64 indicates that BGS should not have too much problems paying its short term obligations.
BGS has a Current ratio of 1.64. This is comparable to the rest of the industry: BGS outperforms 56.04% of its industry peers.
A Quick Ratio of 0.49 indicates that BGS may have some problems paying its short term obligations.
BGS's Quick ratio of 0.49 is on the low side compared to the rest of the industry. BGS is outperformed by 79.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 0.49

1

3. Growth

3.1 Past

The earnings per share for BGS have decreased strongly by -36.70% in the last year.
Measured over the past years, BGS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.66% on average per year.
The Revenue has decreased by -7.04% in the past year.
Measured over the past years, BGS shows a small growth in Revenue. The Revenue has been growing by 3.93% on average per year.
EPS 1Y (TTM)-36.7%
EPS 3Y-24.05%
EPS 5Y-11.66%
EPS Q2Q%-51.85%
Revenue 1Y (TTM)-7.04%
Revenue growth 3Y1.57%
Revenue growth 5Y3.93%
Sales Q2Q%-8.29%

3.2 Future

Based on estimates for the next years, BGS will show a decrease in Earnings Per Share. The EPS will decrease by -7.53% on average per year.
BGS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.92% yearly.
EPS Next Y-29.27%
EPS Next 2Y-18.16%
EPS Next 3Y-7.53%
EPS Next 5YN/A
Revenue Next Year-6.02%
Revenue Next 2Y-3.26%
Revenue Next 3Y-1.92%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.35, the valuation of BGS can be described as reasonable.
Based on the Price/Earnings ratio, BGS is valued cheaply inside the industry as 86.81% of the companies are valued more expensively.
BGS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.55.
The Price/Forward Earnings ratio is 10.77, which indicates a very decent valuation of BGS.
90.11% of the companies in the same industry are more expensive than BGS, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of BGS to the average of the S&P500 Index (24.00), we can say BGS is valued rather cheaply.
Industry RankSector Rank
PE 10.35
Fwd PE 10.77

4.2 Price Multiples

82.42% of the companies in the same industry are more expensive than BGS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, BGS is valued cheaper than 90.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.92
EV/EBITDA 6.5

4.3 Compensation for Growth

BGS's earnings are expected to decrease with -7.53% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-18.16%
EPS Next 3Y-7.53%

5

5. Dividend

5.1 Amount

BGS has a Yearly Dividend Yield of 10.48%, which is a nice return.
In the last 3 months the price of BGS has falen by -23.55%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
BGS's Dividend Yield is rather good when compared to the industry average which is at 3.82. BGS pays more dividend than 100.00% of the companies in the same industry.
BGS's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 10.48%

5.2 History

The dividend of BGS decreases each year by -11.46%.
BGS has been paying a dividend for at least 10 years, so it has a reliable track record.
BGS has decreased its dividend recently.
Dividend Growth(5Y)-11.46%
Div Incr Years0
Div Non Decr Years1

5.3 Sustainability

BGS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The Dividend Rate of BGS has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP-228.13%
EPS Next 2Y-18.16%
EPS Next 3Y-7.53%

B&G FOODS INC

NYSE:BGS (12/26/2024, 6:30:00 PM)

After market: 7.14 0 (0%)

7.14

+0.04 (+0.56%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)N/A N/A
Inst Owners67.67%
Inst Owner Change1.07%
Ins Owners2.94%
Ins Owner Change2.75%
Market Cap565.20M
Analysts48.57
Price Target8.38 (17.37%)
Short Float %13.24%
Short Ratio6.48
Dividend
Industry RankSector Rank
Dividend Yield 10.48%
Dividend Growth(5Y)-11.46%
DP-228.13%
Div Incr Years0
Div Non Decr Years1
Ex-Date12-31 2024-12-31 (0.19)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-27.25%
Min EPS beat(2)-35.09%
Max EPS beat(2)-19.41%
EPS beat(4)1
Avg EPS beat(4)-16.26%
Min EPS beat(4)-35.09%
Max EPS beat(4)3.61%
EPS beat(8)5
Avg EPS beat(8)11.88%
EPS beat(12)5
Avg EPS beat(12)-0.21%
EPS beat(16)5
Avg EPS beat(16)-3.03%
Revenue beat(2)1
Avg Revenue beat(2)-1.26%
Min Revenue beat(2)-3.51%
Max Revenue beat(2)1%
Revenue beat(4)2
Avg Revenue beat(4)-1.13%
Min Revenue beat(4)-3.51%
Max Revenue beat(4)1%
Revenue beat(8)3
Avg Revenue beat(8)-0.55%
Revenue beat(12)4
Avg Revenue beat(12)-0.78%
Revenue beat(16)6
Avg Revenue beat(16)-0.73%
PT rev (1m)-7.26%
PT rev (3m)-7.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.03%
EPS NY rev (1m)-1.6%
EPS NY rev (3m)-7.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.59%
Revenue NY rev (1m)-0.46%
Revenue NY rev (3m)-1.12%
Valuation
Industry RankSector Rank
PE 10.35
Fwd PE 10.77
P/S 0.29
P/FCF 4.92
P/OCF 3.96
P/B 0.75
P/tB N/A
EV/EBITDA 6.5
EPS(TTM)0.69
EY9.66%
EPS(NY)0.66
Fwd EY9.29%
FCF(TTM)1.45
FCFY20.32%
OCF(TTM)1.8
OCFY25.23%
SpS24.75
BVpS9.54
TBVpS-17.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.77%
ROE -3.48%
ROCE 11.44%
ROIC 9.03%
ROICexc 9.21%
ROICexgc 39.12%
OM 16.82%
PM (TTM) N/A
GM 21.87%
FCFM 5.86%
ROA(3y)-0.15%
ROA(5y)1.08%
ROE(3y)-0.64%
ROE(5y)4.67%
ROIC(3y)5.03%
ROIC(5y)5.33%
ROICexc(3y)5.09%
ROICexc(5y)5.39%
ROICexgc(3y)17.45%
ROICexgc(5y)19.68%
ROCE(3y)6.37%
ROCE(5y)6.75%
ROICexcg growth 3Y-6.86%
ROICexcg growth 5Y-0.58%
ROICexc growth 3Y-1.75%
ROICexc growth 5Y5.17%
OM growth 3Y-6.24%
OM growth 5Y3.76%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.37%
GM growth 5Y1.45%
F-Score6
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 2.4
Debt/FCF 18.12
Debt/EBITDA 4.56
Cap/Depr 40.44%
Cap/Sales 1.42%
Interest Coverage 2.07
Cash Conversion 35.82%
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 0.49
Altman-Z 1.45
F-Score6
WACC6.62%
ROIC/WACC1.36
Cap/Depr(3y)39.06%
Cap/Depr(5y)46.27%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.7%
EPS 3Y-24.05%
EPS 5Y-11.66%
EPS Q2Q%-51.85%
EPS Next Y-29.27%
EPS Next 2Y-18.16%
EPS Next 3Y-7.53%
EPS Next 5YN/A
Revenue 1Y (TTM)-7.04%
Revenue growth 3Y1.57%
Revenue growth 5Y3.93%
Sales Q2Q%-8.29%
Revenue Next Year-6.02%
Revenue Next 2Y-3.26%
Revenue Next 3Y-1.92%
Revenue Next 5YN/A
EBIT growth 1Y36.76%
EBIT growth 3Y-4.77%
EBIT growth 5Y7.84%
EBIT Next Year20.74%
EBIT Next 3Y7.72%
EBIT Next 5YN/A
FCF growth 1Y3277.41%
FCF growth 3Y-4.48%
FCF growth 5Y5.75%
OCF growth 1Y336.16%
OCF growth 3Y-4.17%
OCF growth 5Y3.41%